Medicines (MDCO) 10-K2011 FY Annual report

Filed: 29 Feb 12, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: abciximab, ACA, acid, activist, add, adherence, admitted, agenda, alter, altered, amiodarone, angiographic, antitrust, aortic, API, argument, assignee, ATC, Avenue, azithromycin, bactericidal, balloon, BAV, bifurcate, bisulfate, blind, BRAVO, Brilinta, Captisol, Caraco, cast, caution, ceftaroline, Children, clarification, clindamycin, conclusion, constitutional, constitutionality, Contemporaneously, contended, contrast, conventional, convince, curable, CyDex, Daiichi, defective, difficulty, dismissal, dismissing, dispersed, disproportionate, dissection, disseminate, distinct, distract, DOJ, double, Dr, drainage, dramatically, drastic, DSM, efflux, encountered, enlargement, enterococci, erected, escalating, esmolol, excipient, exert, extreme, FCPA, FDAAA, footnote, FTC, FZE, GeNO, Gland, grown, haloperidol, hang, Hatch, heard, highest, hypoxic, implanted, improperly, inaccurate, incapable, incorrectly, inequitable, ingredient, interchangeable, inuring, ISAR, Italia, Justice, Kelly, Ligand, linear, loading, MA, magistrate, Markman, midazolam, midway, milrinone, misuse, Mitigation, moiety, NIH, nitric, noncurable, Obama, ondansetron, oxide, partner, path, Patheon, pathway, payor, periprocedural, pharmacoeconomic, pilot, Plantex, potent, pretrial, prove, qualitative, qualitatively, quantitative, quantity, question, quorum, rata, redacted, Reddy, remote, renegotiate, repealed, respiratory, revoke, revoking, rocuronium, route, run, Sandoz, send, Sixteen, slightly, stable, staggered, stake, strike, stringent, succeed, Sumitomo, Sun, supplementary, TAVI, thereof, thienopyridine, thrombotic, ticagrelor, tiered, tightening, timeline, tranexamic, transcatheter, transport, truthful, tube, turn, UK, unclean, unconditional, unconstitutional, unenforceable, unfractionated, universal, unrelated, usage, vacancy, valvuloplasty, venture, waged, warrant, Waxman, whichever, wire, worthy, XBRL, yearly

Removed: administering, Almac, amputation, anesthesia, ApS, attracting, bacteremia, bear, capability, certified, commercialized, complication, complying, core, Danmark, designate, difficultly, efficiently, emergence, grafting, improving, integrate, integrating, investigator, limb, MERCURY, newly, Nycomed, objected, observational, obstruction, outplacement, package, pharmacological, postmarket, preliminary, profitably, prone, reacquisition, reformulate, relocated, remove, restore, Soviet, territory, transition, transitional, utilize, vein, Vice

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

MDCO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of The Medicines Company (the “Company”) for the period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Clive A. Meanwell, Chairman and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



		By:	/s/ Clive A. Meanwell
			Clive A. Meanwell
			Chairman and Chief Executive Officer

Dated:	February 29, 2012

A signed original of this written statement required by Section 906 has been provided to The Medicines Company and will be retained by The Medicines Company and furnished to the SEC or its staff upon request.